Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award See remarks acquired 161,818 shares (grant or award)
  5. 4/A Open-market sale See remarks sold 1,657 shares at $11.16 ($18,492)
  6. 4/A Open-market sale Chief Financial Officer sold 2,012 shares at $11.16 ($22,454)
  7. 4/A Open-market sale President, R&D sold 2,850 shares at $11.16 ($31,806)
  8. 4/A Open-market sale Chief Legal Officer sold 1,936 shares at $11.16 ($21,606)
  9. 4 Gift Director gave 12,099 shares (gift)
  10. 4 Open-market sale See remarks sold 739 shares at $11.16 ($8,247)
  11. 4 Open-market sale Chief Financial Officer sold 863 shares at $11.16 ($9,631)
  12. 4 Open-market sale President, R&D sold 1,383 shares at $11.16 ($15,434)
  13. 4 Open-market sale Chief Legal Officer sold 863 shares at $11.16 ($9,631)
  14. 4 Open-market sale See remarks sold 297 shares at $15.36 ($4,562)
  15. 4 Open-market sale Chief Financial Officer sold 347 shares at $15.36 ($5,330)
  16. 4 Open-market sale President, R&D sold 763 shares at $15.36 ($11,720)
  17. 4 Open-market sale Chief Legal Officer sold 347 shares at $15.36 ($5,330)
  18. 4 Open-market sale President and CEO sold 42,000 shares at an average $20.99 ($881,720)
  19. 4 Open-market sale See remarks sold 740 shares at $21.56 ($15,954)
  20. 5 Insider Annual Insider Trading Report

Page 9 of 16 · 320 filings